Provided by Tiger Trade Technology Pte. Ltd.

Denali Therapeutics Inc.

18.67
+0.37002.02%
Post-market: 18.670.00000.00%16:12 EDT
Volume:2.47M
Turnover:46.24M
Market Cap:2.96B
PE:-6.29
High:19.15
Open:18.14
Low:18.10
Close:18.30
52wk High:23.77
52wk Low:12.58
Shares:158.59M
Float Shares:144.00M
Volume Ratio:1.30
T/O Rate:1.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.9700
EPS(LYR):-2.9700
ROE:-45.69%
ROA:-27.56%
PB:2.92
PE(LYR):-6.29

Loading ...

Denali Therapeutics announces annual shareholder meeting via webcast

Reuters
·
Apr 22

Denali Therapeutics CMO Peter Scott Chin files initial beneficial ownership statement

Reuters
·
Apr 21

US FDA's accelerated approval for drugs needs more transparency, says research firm

Reuters
·
Apr 16

How AVLAYAH’s Accelerated Approval and Takeda Exit Will Impact Denali Therapeutics (DNLI) Investors

Simply Wall St.
·
Apr 08

BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Norfolk Southern, Denali

Reuters
·
Apr 07

Denali Therapeutics Regains Full Rights to Dementia Drug Following Takeda Partnership Termination

MT Newswires Live
·
Apr 06

Denali Therapeutics regains full rights to DNL593

TIPRANKS
·
Apr 06

Denali regains full rights to DNL593 after Takeda ends collaboration

Reuters
·
Apr 04

Denali Therapeutics Regains Full Rights to Investigational Therapy Dnl593 (Ptv:Pgrn) for Grn-Related Frontotemporal Dementia (Ftd-Grn)

THOMSON REUTERS
·
Apr 04

Denali Therapeutics Inc - to Continue Clinical Development of Dnl593 Using Transportvehicle Technology

THOMSON REUTERS
·
Apr 04

Denali Therapeutics Inc - Results From Phase 1/2 Study in Ftd-Grn Expected by End of 2026

THOMSON REUTERS
·
Apr 04

FDA grants accelerated approval to Denali’s tividenofusp alfa

Reuters
·
Apr 01

Denali Therapeutics Inc - Receives $200 Mln in Gross Proceeds on March 27, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 31

Is Denali Therapeutics’ (DNLI) First Brain-Penetrant Biologic Redefining Its Platform Value Proposition?

Simply Wall St.
·
Mar 30

Stifel Nicolaus Sticks to Its Buy Rating for Denali Therapeutics (DNLI)

TIPRANKS
·
Mar 30

Wedbush Remains a Buy on Denali Therapeutics (DNLI)

TIPRANKS
·
Mar 26

US FDA Approves Avlayah To Treat Neurologic Manifestations Of Hunter Syndrome

Reuters
·
Mar 26

BUZZ-Denali Therapeutics climbs after US FDA approves co's genetic disorder therapy

Reuters
·
Mar 26

US FDA approves Denali's genetic disorder therapy for children

Reuters
·
Mar 25

Denali Therapeutics granted FDA approval of AVLAYAH for treatment of MPS II

TIPRANKS
·
Mar 25